粪便细菌疗法
医学
小肠细菌生长过度
重症监护医学
肠易激综合征
胃肠病学
生物
微生物学
抗生素
艰难梭菌
出处
期刊:PubMed
[National Institutes of Health]
日期:2022-09-25
卷期号:25 (9): 747-756
被引量:10
标识
DOI:10.3760/cma.j.cn441530-20220725-00324
摘要
Fecal microbiota transplantation (FMT) is to transplant the functional intestinal bacteria from human feces into the intestinal tract of patients, reconstruct the new intestinal flora and treat intestinal and extra-intestinal diseases. During the past 10 years, FMT has made a breakthrough in the treatment of intestinal and extra-intestinal diseases, and provided a brand-new strategy to the treatment of intestinal and extra-intestinal diseases. In view of the fact that FMT lacks a unified clinical management standard at home and abroad, relevant regulations and policies still need to be improved, and clinical application experience still needs to be accumulated, the National Institute of Hospital Administration, National Health Commission commissioned a clinical FMT expert working group to organize experts in related fields. Based on thorough analysis of relevant literature, policies and norms internationally, as well as the mature experience of FMT in many medical institutions in China, an expert consensus for clinical management of FMT in medical institutions is compiled to further strengthen its clinical application and standard management, so as to improve the safety and efficacy of FMT.
科研通智能强力驱动
Strongly Powered by AbleSci AI